High-dose planned adaptive helical tomotherapy for cutaneous angiosarcoma of the scalp
ConclusionPlanned adaptive high-dose IMRT with HT has the potential to improve local control rate without increasing adverse events. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - June 1, 2023 Category: Cancer & Oncology Source Type: research
CT-based radiomics prediction of complete response after stereotactic body radiation therapy for patients with lung metastases
ConclusionThis analysis demonstrates that radiomics features obtained from pretreatment CT could predict complete response of lung oligometastases following SBRT. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - May 31, 2023 Category: Cancer & Oncology Source Type: research
The role of EPID in vivo dosimetry in the risk management of stereotactic lung treatments
ConclusionThe use of IVD allowed the quality of lung stereotactic body radiation therapy (SBRT) treatments to be improved. Patient-specific and procedural corrective actions were successfully taken as part of risk management, leading to an overall improvement in the dosimetric accuracy. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - May 31, 2023 Category: Cancer & Oncology Source Type: research
Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity
ConclusionOur analysis depicted an association between the dose to OAR and the risk of developing moderate to severe dysphagia and dysgeusia and proposed new dose constraints for PCM (36.7 Gy) and oral cavity (20.5 Gy). (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - May 31, 2023 Category: Cancer & Oncology Source Type: research
CT-based radiomics prediction of complete response after stereotactic body radiation therapy for patients with lung metastases
ConclusionThis analysis demonstrates that radiomics features obtained from pretreatment CT could predict complete response of lung oligometastases following SBRT. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - May 31, 2023 Category: Cancer & Oncology Source Type: research
The role of EPID in vivo dosimetry in the risk management of stereotactic lung treatments
ConclusionThe use of IVD allowed the quality of lung stereotactic body radiation therapy (SBRT) treatments to be improved. Patient-specific and procedural corrective actions were successfully taken as part of risk management, leading to an overall improvement in the dosimetric accuracy. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - May 31, 2023 Category: Cancer & Oncology Source Type: research
Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity
ConclusionOur analysis depicted an association between the dose to OAR and the risk of developing moderate to severe dysphagia and dysgeusia and proposed new dose constraints for PCM (36.7 Gy) and oral cavity (20.5 Gy). (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - May 31, 2023 Category: Cancer & Oncology Source Type: research
Dosiseskalation mittels Brachytherapie zur Erh öhung der Organerhaltungsrate beim Rektumkarzinom
(Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - May 16, 2023 Category: Cancer & Oncology Source Type: research
Hyalurons äurespacer zur Optimierung der Rektumdosis bei hypofraktionierter Radiotherapie der Prostata
(Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - May 8, 2023 Category: Cancer & Oncology Source Type: research
Pr äoperative Therapie beim Pankreaskarzinom: Daten der A021501-Studie
(Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - May 8, 2023 Category: Cancer & Oncology Source Type: research
A nomogram to predict the cumulative risk for brain metastases in patients with limited-stage small cell lung cancer without prophylactic cranial irradiation
ConclusionThe present study has developed an innovative tool that is able to predict the individual cumulative risk for development of BM in LS-SCLC patients without PCI, which is beneficial for providing personalized risk estimates and facilitating the decision to perform PCI. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - April 27, 2023 Category: Cancer & Oncology Source Type: research
Brooke –Spiegler syndrome: radiotherapy as the last resort?
ConclusionThis case should remind us of the potential role that radiotherapy could play in treating Brooke –Spiegler syndrome. The required dose for treatment of such extensive disease is still a matter of debate due to the scarcity of radiotherapeutic experience. This case demonstrates that for scalp tumors, 30 × 2 Gy can result in long-term tumor control, while other dose prescriptions may be adequate for tumors in other locations. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - April 27, 2023 Category: Cancer & Oncology Source Type: research
Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community
ConclusionIdentification of patients at an increased risk of RD and subsequent implementation of adequate preventive measures remain relevant and challenging aspects of clinical routines. Consensus exists on several risk factors and nonpharmaceutical prevention recommendations, while RT-dependent risk factors, e.g., the fractionation scheme, or hygienic measures like deodorant use remain controversial. Surveillance is widely lacking methodology and objectivity. Intensifying outreach in the radiation oncology community is needed to improve practice patterns. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - April 26, 2023 Category: Cancer & Oncology Source Type: research
Safety and efficacy associated with single-fraction high-dose-rate brachytherapy in localized prostate cancer: a systematic review and meta-analysis
ConclusionSFHDR is associated with favorable tolerability and suboptimal clinical benefit in patients with localized prostate cancer. Ongoing and planned high-quality prospective studies are necessary to verify its safety and efficacy. (Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - April 24, 2023 Category: Cancer & Oncology Source Type: research
Gute Therapievertr äglichkeit und Lebensqualität nach primär organerhaltender Therapie des frühen Rektumkarzinoms: Ergebnisse der TREC-Studie
(Source: Strahlentherapie und Onkologie)
Source: Strahlentherapie und Onkologie - April 21, 2023 Category: Cancer & Oncology Source Type: research
